SCHEMBL7089537

SCHEMBL7089537

Cc1cc(C)c2cccc(C)c2c1C.Cc1ccc2c(c1)cc(C)c1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.46
CYP2A6 P11509 6/20 0.40
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 2/20 0.33
MAOA P21397 2/20 0.33
KIF11 P52732 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
NQO2 P16083 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
HCRTR1 O43613 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL599080 0.83 CYP1A2 (0.54) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL598808 0.80 CYP1A2 (0.48) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL597878 0.75 CYP1A2 (0.73) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL27832989 0.71 CYP1A2 (0.50) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL9038677 0.71 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL599403 0.70 CYP2A6 (0.52) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL30661085 0.70 CYP2A6 (0.52) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL27280211 0.69 CYP1A2 (0.40) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL8562301 0.69 CYP1A2 (0.54) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL5251220 0.68 CYP1A2 (0.50) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162992-A1 Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde PHARMASSET, INC. 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162992-A1 Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde DERA, DPYD, DHPS CYP1A2 592/4885CYP2A6 1024/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.